For instance, the combination of venetoclax and MCL-1 inhibitor produced a synergistic apoptotic response in acute myeloid leukemia (AML) cells in vitro compared to the administration of venetoclax alone [42]. Here, MCL1 is linked to acute myeloid leukemia.